These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2324958)

  • 1. Bioadhesive lozenge for the improved delivery of cetylpyridinium chloride.
    Collins AE; Deasy PB
    J Pharm Sci; 1990 Feb; 79(2):116-9. PubMed ID: 2324958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buccoadhesive erodible disk for treatment of oro-dental infections: design and characterisation.
    Ali J; Khar R; Ahuja A; Kalra R
    Int J Pharm; 2002 May; 238(1-2):93-103. PubMed ID: 11996813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buccoadhesive tablets for the slow delivery of cetylpyridinium chloride: design and in vitro/in vivo analysis.
    Minghetti P; Pacchetti B; Montanari L; Ronchi C; Berlati F
    Boll Chim Farm; 1997; 136(7):543-8. PubMed ID: 9432193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excipient interaction with cetylpyridinium chloride activity in tablet based lozenges.
    Richards RM; Xing JZ; Mackay KM
    Pharm Res; 1996 Aug; 13(8):1258-64. PubMed ID: 8865323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of formulation on the antimicrobial activity of cetylpyridinium chloride in candy based lozenges.
    Richards RM; Xing JZ; Weir LF
    Pharm Res; 1996 Apr; 13(4):583-7. PubMed ID: 8710750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of 8 mg lidocaine and 2 mg cetylpyridinium chloride (CPC) fixed-combination lozenges on sore throat pain intensity compared with 1 mg lidocaine and 2 mg CPC fixed-combination lozenges in subjects with sore throat due to upper respiratory tract infection: a randomized double-blind parallel-group single-dose study.
    Donath F; Mallefet P; Garreffa S; Furcha R
    Trials; 2018 Dec; 19(1):679. PubMed ID: 30541606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cetylpyridinium chloride].
    Farmatsiia; 1977; 26(2):88-9. PubMed ID: 862969
    [No Abstract]   [Full Text] [Related]  

  • 8. Design and characterization of mucoadhesive buccal patches containing cetylpyridinium chloride.
    Nafee NA; Boraie MA; Ismail FA; Mortada LM
    Acta Pharm; 2003 Sep; 53(3):199-212. PubMed ID: 14769243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioadhesive dosage form for peroral administration of timolol base.
    Deasy PB; O'Neill CT
    Pharm Acta Helv; 1989; 64(8):231-5. PubMed ID: 2780757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and study of lamivudine oral controlled release tablets.
    Ravi PR; Ganga S; Saha RN
    AAPS PharmSciTech; 2007 Dec; 8(4):E101. PubMed ID: 18181522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-layered mucoadhesive tablets containing nystatin.
    Llabot JM; Manzo RH; Allemandi DA
    AAPS PharmSciTech; 2002; 3(3):E22. PubMed ID: 12916937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-Layered Matrix of Shellac Wax-Lutrol in Controlled Dual Drug Release.
    Phaechamud T; Choncheewa CE
    AAPS PharmSciTech; 2016 Dec; 17(6):1326-1335. PubMed ID: 26694059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro and in-vivo characteristics of a modified-release double-pulse formulation for a water soluble drug.
    Avramoff A; Domb AJ
    Int J Clin Pharmacol Ther; 2010 Apr; 48(4):250-8. PubMed ID: 20353746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the quaternary ammonium compounds dequalinium and cetylpyridinium chlorides in candy-based lozenges by high-performance liquid chromatography.
    Taylor RB; Toasaksiri S; Reid RG; Wood D
    Analyst; 1997 Sep; 122(9):973-6. PubMed ID: 9374026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S; Faraj J; DeLuca P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel system for three-pulse drug release based on "tablets in capsule" device.
    Li B; Zhu J; Zheng C; Gong W
    Int J Pharm; 2008 Mar; 352(1-2):159-64. PubMed ID: 18055142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and in vitro evaluation of zidovudine oral controlled release tablets prepared using hydroxypropyl methylcellulose.
    Ravi PR; Ganga S; Saha RN
    Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):518-24. PubMed ID: 18379101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and testing of bioadhesive, fluoride-containing slow-release tablets for oral use.
    Bottenberg P; Cleymaet R; de Muynck C; Remon JP; Coomans D; Michotte Y; Slop D
    J Pharm Pharmacol; 1991 Jul; 43(7):457-64. PubMed ID: 1682457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QbD-Oriented Development and Characterization of Effervescent Floating-Bioadhesive Tablets of Cefuroxime Axetil.
    Bansal S; Beg S; Garg B; Asthana A; Asthana GS; Singh B
    AAPS PharmSciTech; 2016 Oct; 17(5):1086-99. PubMed ID: 26527606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.